| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Cutaneous Biology Research Center and Department of Dermatology,* Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts; the Departments of Pathology and Biostatistics, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; the Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts; the Institute of Molecular Medicine,¶ John Radcliffe Hospital, Headington, Oxford, United Kingdom; and the Department of Dermatology,|| University of Tübingen Medical School, Tübingen, Germany
Malignant melanomas of the skin are distinguished by their propensity for early metastatic spread via lymphatic vessels to regional lymph nodes, and lymph node metastasis is a major determinant for the staging and clinical management of melanoma. However, the importance of tumor-induced lymphangiogenesis for lymphatic melanoma spread has remained unclear. We investigated whether tumor lymphangiogenesis occurs in human malignant melanomas of the skin and whether the extent of tumor lymphangiogenesis may be related to the risk for lymph node metastasis and to patient survival, using double immunostains for the novel lymphatic endothelial marker LYVE-1 and for the panvascular marker CD31. Tumor samples were obtained from clinically and histologically closely matched cases of primary melanomas with early lymph node metastasis (n = 18) and from nonmetastatic melanomas (n = 19). Hot spots of proliferating intratumoral and peritumoral lymphatic vessels were detected in a large number of melanomas. The incidence of intratumoral lymphatics was significantly higher in metastatic melanomas and correlated with poor disease-free survival. Metastatic melanomas had significantly more and larger tumor-associated lymphatic vessels, and a relative lymphatic vessel area of >1.5% was significantly associated with poor disease-free and overall survival. In contrast, no differences in the density of tumor-associated blood vessels were found. Vascular endothelial growth factor and vascular endothelial growth factor-C expression was equally detected in a minority of cases in both groups. Our results reveal tumor lymphangiogenesis as a novel prognostic indicator for the risk of lymph node metastasis in cutaneous melanoma.
Related articles in Am J Pathol:
This article has been cited by other articles:
 |
|
 |
|
  L. M. Heindl, T. N. Hofmann, H. L. J. Knorr, C. Rummelt, F. Schrodl, U. Schlotzer-Schrehardt, L. M. Holbach, G. O. H. Naumann, F. E. Kruse, and C. Cursiefen Intraocular Lymphangiogenesis in Malignant Melanomas of the Ciliary Body with Extraocular Extension Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 1988 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lahat, A. Lazar, X. Wang, W.-L. Wang, Q.-S. Zhu, K. K. Hunt, R. E. Pollock, and D. Lev Increased Vascular Endothelial Growth Factor-C Expression Is Insufficient to Induce Lymphatic Metastasis in Human Soft-Tissue Sarcomas Clin. Cancer Res., April 15, 2009; 15(8): 2637 - 2646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nguyen Huu, M. Oster, M.-F. Avril, F. Boitier, L. Mortier, M.-A. Richard, D. Kerob, E. Maubec, P. Souteyrand, P. Moguelet, et al. Fetal Microchimeric Cells Participate in Tumour Angiogenesis in Melanomas Occurring during Pregnancy Am. J. Pathol., February 1, 2009; 174(2): 630 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Saad, J. L. Lindner, Y. Liu, and J. F. Silverman Lymphangiogenesis in Esophageal Adenocarcinomas--Lymphatic Vessel Density as Prognostic Marker in Esophageal Adenocarcinoma Am J Clin Pathol, January 1, 2009; 131(1): 92 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. K. Sondak and J. L. Messina Lymphangiogenesis: Host and Tumor Factors in Nodal Metastasis Arch Dermatol, April 1, 2008; 144(4): 536 - 537. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Choi and J.N. Myers Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy Journal of Dental Research, January 1, 2008; 87(1): 14 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Cassarino, E. S. Cabral, R. V. Kartha, and S. M. Swetter Primary Dermal Melanoma: Distinct Immunohistochemical Findings and Clinical Outcome Compared With Nodular and Metastatic Melanoma Arch Dermatol, January 1, 2008; 144(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B S M S Siriwardena, Y Kudo, I Ogawa, M N G P K Udagama, W M Tilakaratne, and T Takata VEGF-C is associated with lymphatic status and invasion in oral cancer J. Clin. Pathol., January 1, 2008; 61(1): 103 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Koyama, N. Kobayashi, M. Harada, M. Takeoka, Y. Kawai, K. Sano, M. Fujimori, J. Amano, T. Ohhashi, R. Kannagi, et al. Significance of Tumor-Associated Stroma in Promotion of Intratumoral Lymphangiogenesis: Pivotal Role of a Hyaluronan-Rich Tumor Microenvironment Am. J. Pathol., January 1, 2008; 172(1): 179 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Iwata, M. R. Kano, A. Komuro, M. Oka, K. Kiyono, E. Johansson, Y. Morishita, M. Yashiro, K. Hirakawa, M. Kaminishi, et al. Inhibition of Cyclooxygenase-2 Suppresses Lymph Node Metastasis via Reduction of Lymphangiogenesis Cancer Res., November 1, 2007; 67(21): 10181 - 10189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Sundar and T. S. Ganesan Role of Lymphangiogenesis in Cancer J. Clin. Oncol., September 20, 2007; 25(27): 4298 - 4307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A B Soares, L Ponchio, P B Juliano, V C de Araujo, and A Altemani Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma J. Clin. Pathol., September 1, 2007; 60(9): 995 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hirakawa, L. F. Brown, S. Kodama, K. Paavonen, K. Alitalo, and M. Detmar VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites Blood, February 1, 2007; 109(3): 1010 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wissmann and M. Detmar Pathways Targeting Tumor Lymphangiogenesis Clin. Cancer Res., December 1, 2006; 12(23): 6865 - 6868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Becker, M. C. Mihm, S. M. Hewitt, V. K. Sondak, J. W. Fountain, and M. Thurin Markers and Tissue Resources for Melanoma: Meeting Report. Cancer Res., November 15, 2006; 66(22): 10652 - 10657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Tobler and M. Detmar Tumor and lymph node lymphangiogenesis--impact on cancer metastasis J. Leukoc. Biol., October 1, 2006; 80(4): 691 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Posther, M. A. Selim, P. J. Mosca, W. E. Stanley, J. L. Johnson, D. S. Tyler, and H. F Seigler Histopathologic Characteristics, Recurrence Patterns, and Survival of 129 Patients With Desmoplastic Melanoma Ann. Surg. Oncol., May 1, 2006; 13(5): 728 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Fiedler, S. Christian, S. Koidl, D. Kerjaschki, M. S. Emmett, D. O. Bates, G. Christofori, and H. G. Augustin The Sialomucin CD34 Is a Marker of Lymphatic Endothelial Cells in Human Tumors Am. J. Pathol., March 1, 2006; 168(3): 1045 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ohta, Y. Shimizu, H. Minato, I. Matsumoto, M. Oda, and G. Watanabe Results of Initial Operations in Non-Small Cell Lung Cancer Patients With Single-Level N2 Disease Ann. Thorac. Surg., February 1, 2006; 81(2): 427 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Massi, S Puig, A Franchi, J Malvehy, S Vidal-Sicart, M Gonzalez-Cao, G Baroni, S Ketabchi, J Palou, and M Santucci Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study J. Clin. Pathol., February 1, 2006; 59(2): 166 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Hodi Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage Clin. Cancer Res., February 1, 2006; 12(3): 673 - 678. [Full Text] [PDF]
|
|
|
|
|
|
Y. Miyata, S. Kanda, K. Ohba, K. Nomata, Y. Hayashida, J. Eguchi, T. Hayashi, and H. Kanetake Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D Clin. Cancer Res., February 1, 2006; 12(3): 800 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Religa, R. Cao, M. Bjorndahl, Z. Zhou, Z. Zhu, and Y. Cao Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels Blood, December 15, 2005; 106(13): 4184 - 4190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gombos, X. Xu, C. S. Chu, P. J. Zhang, and G. Acs Peritumoral Lymphatic Vessel Density and Vascular Endothelial Growth Factor C Expression in Early-Stage Squamous Cell Carcinoma of the Uterine Cervix Clin. Cancer Res., December 1, 2005; 11(23): 8364 - 8371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Renyi-Vamos, J. Tovari, J. Fillinger, J. Timar, S. Paku, I. Kenessey, G. Ostoros, L. Agocs, I. Soltesz, and B. Dome Lymphangiogenesis Correlates with Lymph Node Metastasis, Prognosis, and Angiogenic Phenotype in Human Non-Small Cell Lung Cancer Clin. Cancer Res., October 15, 2005; 11(20): 7344 - 7353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Sahni, A Robson, G Orchard, R Szydlo, A V Evans, and R Russell-Jones The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status J. Clin. Pathol., July 1, 2005; 58(7): 715 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ackermann, M. Frutschi, K. Kaloulis, T. McKee, A. Trumpp, and F. Beermann Metastasizing Melanoma Formation Caused by Expression of Activated N-RasQ61K on an INK4a-Deficient Background Cancer Res., May 15, 2005; 65(10): 4005 - 4011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hirakawa, S. Kodama, R. Kunstfeld, K. Kajiya, L. F. Brown, and M. Detmar VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis J. Exp. Med., April 4, 2005; 201(7): 1089 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Schacht, S. S. Dadras, L. A. Johnson, D. G. Jackson, Y.-K. Hong, and M. Detmar Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type Transmembrane Glycoprotein, in Human Squamous Cell Carcinomas and Germ Cell Tumors Am. J. Pathol., March 1, 2005; 166(3): 913 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tammela, B. Enholm, K. Alitalo, and K. Paavonen The biology of vascular endothelial growth factors Cardiovasc Res, February 15, 2005; 65(3): 550 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M I Koukourakis, A Giatromanolaki, E Sivridis, C Simopoulos, K C Gatter, A L Harris, and D G Jackson LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer J. Clin. Pathol., February 1, 2005; 58(2): 202 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bono, V.-M. Wasenius, P. Heikkila, J. Lundin, D. G. Jackson, and H. Joensuu High LYVE-1-Positive Lymphatic Vessel Numbers Are Associated with Poor Outcome in Breast Cancer Clin. Cancer Res., November 1, 2004; 10(21): 7144 - 7149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sipos, W. Klapper, M.-L. Kruse, H. Kalthoff, D. Kerjaschki, and G. Kloppel Expression of Lymphangiogenic Factors and Evidence of Intratumoral Lymphangiogenesis in Pancreatic Endocrine Tumors Am. J. Pathol., October 1, 2004; 165(4): 1187 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. McMasters Editorial: What Good is Sentinel Lymph Node Biopsy for Melanoma if it does not Improve Survival? Ann. Surg. Oncol., September 1, 2004; 11(9): 810 - 812. [Full Text] [PDF]
|
|
|
|
|
|
R. Kunstfeld, S. Hirakawa, Y.-K. Hong, V. Schacht, B. Lange-Asschenfeldt, P. Velasco, C. Lin, E. Fiebiger, X. Wei, Y. Wu, et al. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia Blood, August 15, 2004; 104(4): 1048 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M M Vleugel, R Bos, P van der Groep, A E Greijer, A Shvarts, H V Stel, E van der Wall, and P J van Diest Lack of lymphangiogenesis during breast carcinogenesis J. Clin. Pathol., July 1, 2004; 57(7): 746 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Garcia de la Torre, I. Buley, J. A. H. Wass, D. G. Jackson, and H. E. Turner Angiogenesis and Lymphangiogenesis in Parathyroid Proliferative Lesions J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2890 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. North, T. Kahn, M. R. Cordisco, S. S. Dadras, M. Detmar, and I. J. Frieden Multifocal Lymphangioendotheliomatosis With Thrombocytopenia: A Newly Recognized Clinicopathological Entity Arch Dermatol, May 1, 2004; 140(5): 599 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Colvin Emphatically Lymphatic J. Am. Soc. Nephrol., March 1, 2004; 15(3): 827 - 829. [Full Text] [PDF]
|
|
|
|
|
|
T. P. Padera, Y. Boucher, R. K. Jain, L. M. Wein, P. E. Holden, and D. H. Kirn Correspondence re: S. Maula et al., Intratumoral Lymphatics Are Essential for the Metastatic Spread and Prognosis in Squamous Cell Carcinoma of the Head and Neck. Cancer Res., 63: 1920-1926, 2003. Cancer Res., December 1, 2003; 63(23): 8555 - 8557. [Full Text] [PDF]
|
|
|
|
 |
|
 Lymphangiogenesis in Malignant Melanoma: The New Prognostic Factor on the Block Journal Watch Dermatology, August 12, 2003; 2003(812): 4 - 4. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
